Cochlear Implant

A cochlear implant is a two-part hearing system. The external sound processor sits behind the ear or on the head, picks up sound through microphones and converts it into a coded signal. That signal passes through the skin by a magnetic link to an implanted receiver that sits under the skin behind the ear. From the receiver, a very fine electrode array runs into the cochlea, the spiral organ of the inner ear, and delivers small electrical pulses along the hearing nerve. The brain learns to interpret these pulses as sound. Because the implant replaces the function of the damaged hair cells rather than amplifying sound, it can give speech understanding to people for whom even powerful hearing aids do very little.

Cochlear implantation is considered for severe to profound sensorineural hearing loss in one or both ears when properly fitted hearing aids no longer allow reliable understanding of speech. In children this includes hearing loss present from birth and hearing lost after meningitis or other illness, and implantation is generally planned as early as the assessment allows so that spoken language can develop. In adults it is offered for hearing loss that has progressed over years, for sudden hearing loss that did not recover, for loss caused by certain medicines and for some cases of deafness in one ear only. The decision rests on hearing tests, speech testing with hearing aids in place, imaging of the inner ear and hearing nerve, and a discussion of what the individual hopes to gain.

The operation is performed under general anaesthesia. The surgeon makes a small incision behind the ear and prepares a shallow bed in the bone of the skull for the receiver. Working through the mastoid bone, a narrow channel is opened to the middle ear and then to the cochlea, and the electrode array is gently threaded into the spiral of the inner ear. The receiver is fixed in its bed and the incision is closed, so nothing is visible afterwards except a fine scar hidden by hair. During surgery the team measures the response of the hearing nerve to confirm the electrodes are working. Implanting one ear usually takes about 2 to 3 hours, and both ears in one session take longer. The device stays switched off while the tissue heals.

Candidacy is decided by an ear surgeon and an audiologist together. Assessment includes pure tone and speech audiometry, testing with optimally fitted hearing aids, a scan of the temporal bone and often magnetic resonance imaging to confirm that the cochlea and hearing nerve are suitable, and a general check of fitness for anaesthesia. For children, speech and language assessment and family counselling are part of the pathway, because daily use of the processor and consistent therapy shape the result. Vaccination against pneumococcal infection is recommended before implantation. Before travelling, hearing test results, previous scans and hearing aid history can usually be reviewed remotely, so the visit begins with confirmation rather than a first assessment.

Most patients go home the same day or after one night. Some dizziness, a full feeling in the ear and mild discomfort around the wound are common in the first days and settle quickly. The dressing comes off within a few days and the wound is checked at about one week. The processor is fitted and switched on once the swelling has gone down, usually 2 to 4 weeks after surgery, and this first activation is followed by a series of programming sessions in which the sound is adjusted to what the individual hears. Planning treatment abroad therefore has two shapes: a shorter trip of about 7 to 10 days for the surgery, with activation and programming arranged closer to home, or a longer stay that covers activation as well. International patient teams help arrange the sequence and provide interpreters, and later programming and listening therapy can often be shared with an audiologist at home under an agreed plan.

Cochlear implantation is a well-established operation with a good safety record, and serious complications are uncommon. Expected effects include temporary dizziness, altered taste on one side of the tongue, numbness around the ear and mild swelling. Less common risks include wound infection, fluid collection under the skin, injury to the facial nerve, persistent tinnitus, and device failure that would need a further operation to replace the implant. Any residual natural hearing in the implanted ear may be reduced or lost. Results vary: most adults implanted after a relatively short period of deafness gain useful speech understanding, often on the telephone as well, while those deaf for many decades may gain awareness of sound and lip-reading support rather than open speech. Children implanted early and supported with consistent therapy commonly develop spoken language.